A first-in-human phase I study of SAR125844, a selective...

European Journal of Cancer 2017 / 12 Vol. 87

A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification

Angevin, Eric, Spitaleri, Gianluca, Rodon, Jordi, Dotti, Katia, Isambert, Nicolas, Salvagni, Stefania, Moreno, Victor, Assadourian, Sylvie, Gomez, Corinne, Harnois, Marzia, Hollebecque, Antoine, Azaro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
87
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2017.10.016
Date:
December, 2017
File:
PDF, 470 KB
english, 2017
Conversion to is in progress
Conversion to is failed